The UK annual economic cost of dementia estimated to be £23 billion (almost equalling the combined costs of cancer, heart disease and stroke), yet effective therapies remain elusive. Can genomics help?
A new report endorsed by the Garvan Institute in Sydney sets out current and emerging health and commercial applications of genomics.
The House of Commons Science and Technology Committee has today released a major report, Genomics and genome editing in the NHS, the result of an extensive inquiry conducted in 2017.
Philippa Brice gives a detailed overview of a new report from the House of Commons Science and Technology Committee ‘Genomics and genome editing in the NHS’
Genomics has the potential to revolutionise diagnosis, screening, prevention and therapeutics, but to incorporate it into healthcare will require a shift in attitudes and expectations surrounding data sharing and confidentiality
The important annual report of the Chief Medical Officer (CMO) for England, Prof Dame Sally Davies, has been released today, and it is focused solely on genomics
Opportunities and challenges presented by the introduction of genomic analysis
As understanding of the genetic basis for obesity improves, is it time for a rethink?